Molecular screening for CGG repeat expansions of the FMR1 gene is now recommended for all individuals diagnosed with ASD due to the high levels of comorbidity between ASD and FXS and the variable expressiveness of FXS [9, 29–32]. This evidence concerns the gene FMR1 and fragile X syndrome.